A comprehensive strategy sets the stage for a new phase at Target 2035
We describe the Target 2035 roadmap to develop computational methods to improve small-molecule hit discovery, which is a key bottleneck in the discovery of chemical probes.
We describe the Target 2035 roadmap to develop computational methods to improve small-molecule hit discovery, which is a key bottleneck in the discovery of chemical probes.
Toronto, Ontario – July 3, 2024 – The Structural Genomics Consortium (SGC) is pleased to announce the appointment of Dr. Peter Sampson as the new Vice President of Drug Discovery and Development for SGC’s affiliate Canadian charity, Agora Open Science Trust (Agora).